Karolien De Bosscher

8PUBLICATIONS
20CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 15, 2024
NCOR1/2 and glucocorticoid receptor orchestrate hepatic function.

Chloé Van Leene, Karolien De Bosscher

|Aug 14, 2023
Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells.

Dorien Clarisse, Stefan Prekovic, Philip Vlummens

|Jun 28, 2023
The Biologist's Guide to the Glucocorticoid Receptor's Structure.

Nick Deploey, Laura Van Moortel, Inez Rogatsky

|Aug 17, 2021
How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer.

Dorien Clarisse, Karolien De Bosscher

|Apr 19, 2020
Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Karolien De Bosscher, Sofie J Desmet, Dorien Clarisse

|Jun 12, 2019
TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

Karen Dendoncker, Steven Timmermans, Jolien Vandewalle

Pageof 2